Clinical Trials Directory

Trials / Unknown

UnknownNCT02928484

Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function

Evaluación Del Efecto Del Suplemento Nutricional probiótico "Biopolis" Sobre la función Gastrointestinal

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Biopolis S.L. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this pilot study is to evaluate whether a probiotic supplement improves gastrointestinal (GI) function.

Detailed description

Sixty volunteers with functional GI disorders (Functional dyspepsia according to Rome-III criteria) will be recruited for a randomised, double-blind, placebo-controlled, two-arm parallel study in which the effect upon the gastrointestinal function of a probiotic mix containing bifidobacteria and lactobacilli (manufactured by Biopolis SL) will be compared with placebo (maltodextrin). The study design includes a 4 week run-in period, in which the volunteers will not consume any probiotics/prebiotics, followed by a 4 weeks intervention period (a daily capsule of placebo or probiotic) and an 8 weeks washout period. At the beginning/end of each period questionnaires in gastrointestinal function, dyspepsia related symptoms and diet will be carried out. A serum sample will be taken for cytokine levels determination. A faecal sample will be taken for 16S microbial population profiling and for determining the faecal levels of Bifidobacterium, Bacteriodes, Faecalibacterium, Akkermansia, Lactobacillus and Blautia by qPCR and the concentration of the main bacterial metabolites; acetate, propionate and butyrate by gas-chromatography.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic mix CBP-004019/COne capsule per day of the probiotic mix CBP-004019/C during one month.
DIETARY_SUPPLEMENTPlaceboOne capsule per day of the placebo (maltodextrin) during one month.

Timeline

Start date
2016-06-01
Primary completion
2017-06-01
Completion
2017-12-01
First posted
2016-10-10
Last updated
2016-10-10

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02928484. Inclusion in this directory is not an endorsement.